Eagle Pharmaceuticals, Inc. Intangible Assets, Net (Excluding Goodwill)
Eagle Pharmaceuticals, Inc. had Intangible Assets, Net (Excluding Goodwill) of $107.41 million as of 2023-06-30, per its 10-Q/A filed 2023-08-09.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization
us-gaap:IntangibleAssetsNetExcludingGoodwill · last filed 2023-08-09
- 2023-06-30: Intangible Assets, Net (Excluding Goodwill) $107.41M.
- 2023-03-31: Intangible Assets, Net (Excluding Goodwill) $112.88M.
- 2022-12-31: Intangible Assets, Net (Excluding Goodwill) $118.33M.
- 2022-09-30: Intangible Assets, Net (Excluding Goodwill) $108.78M.
| Period end | Intangible Assets, Net (Excluding Goodwill) |
|---|---|
| 2023-06-30 | $107.41M 10-Q/A · filed 2023-08-09 |
| 2023-03-31 | $112.88M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $118.33M 10-Q/A · filed 2023-08-09 |
| 2022-09-30 | $108.78M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $112.47M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $9.94M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $10.67M 10-K · filed 2023-03-23 |
| 2021-09-30 | $10.80M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $11.51M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $12.21M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $12.92M 10-K · filed 2022-03-08 |
| 2020-09-30 | $13.58M 10-Q · filed 2020-11-02 |
| 2020-06-30 | $14.25M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $14.92M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $15.58M 10-K · filed 2021-03-05 |
| 2019-09-30 | $16.21M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $16.84M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $17.47M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $18.10M 10-K · filed 2020-03-02 |
| 2018-09-30 | $18.70M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $19.30M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $22.65M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $23.32M 10-K · filed 2019-02-28 |
| 2017-09-30 | $24.00M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $31.95M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $32.66M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $33.37M 10-K · filed 2018-02-26 |
| 2016-09-30 | $24.76M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $10.96M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $11.12M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-15 |